My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
March 2017
Faces of Antimicrobial Resistance: Bringing Patient Stories to Capitol Hill

Simon Sparrow was only 15 months old when a drug-resistant infection took his life. Since that dreadful day in 2004, his brave mother, Everly Macario, has shared her story countless times to help raise awareness about antimicrobial resistance and to garner the resources needed to help other children and adults.

This month, IDSA shared Simon’s story and those of many others in the Society’s Faces of Antimicrobial Resistance (FOAR) (PDF) report at a congressional briefing to provide policymakers an overview of federal AR activities. The briefing included IDSA President-elect Paul Auwaerter, MD, FIDSA; Director of the National Institute of Allergy and Infectious Diseases Tony Fauci, MD, FIDSA; Acting Director of the Centers for Disease Control and Prevention Anne Schuchat, MD; Acting Assistant Secretary of Defense for Health Affairs David Smith, and Director of the Biomedical Advanced Research and Development Authority Rick Bright, PhD.

The FOAR report features stories of patients across the country who have been impacted by drug resistance. Stories such as these are essential in IDSA’s efforts to advocate for policies to address antimicrobial resistance, and we are grateful to IDSA members who connected us with many of the patients included in this report. We will continue adding stories to our website—please let us know if you have a patient who would be willing to share their story.

IDSA is advocating for Congress to provide robust funding for federal AR activities, including stewardship, surveillance, prevention, research, and development of new therapies, vaccines and diagnostics. Please click here to contact your Senators and Representatives, or call them via the Capitol Switchboard at 202-224-3121. This website can tell you who your Senators and Representatives are.

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:

CLSI Subcommittee on Antimicrobial Susceptibility Testing
Averting a Repeal of the ACA
Safe Consumption: Facing the Opioid Epidemic
Science Speaks Covers Transition Plans, Response
Strengthening the ID Physician-Scientist Workforce
A Voice for Science in Washington, DC
Faces of Antimicrobial Resistance: Bringing Patient Stories to Capitol Hill
IDWeek Abstracts and Cases are Due May 17óDonít Miss Out
Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add '' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.